Moreno-Lanceta, A.; Medrano-Bosch, M.; Simón-Codina, B.; Barber-González, M.; Jiménez, W.; Melgar-Lesmes, P.
PPAR-γ Agonist GW1929 Targeted to Macrophages with Dendrimer–Graphene Nanostars Reduces Liver Fibrosis and Inflammation. Pharmaceutics 2023, 15, 1452.
https://doi.org/10.3390/pharmaceutics15051452
AMA Style
Moreno-Lanceta A, Medrano-Bosch M, Simón-Codina B, Barber-González M, Jiménez W, Melgar-Lesmes P.
PPAR-γ Agonist GW1929 Targeted to Macrophages with Dendrimer–Graphene Nanostars Reduces Liver Fibrosis and Inflammation. Pharmaceutics. 2023; 15(5):1452.
https://doi.org/10.3390/pharmaceutics15051452
Chicago/Turabian Style
Moreno-Lanceta, Alazne, Mireia Medrano-Bosch, Blanca Simón-Codina, Montserrat Barber-González, Wladimiro Jiménez, and Pedro Melgar-Lesmes.
2023. "PPAR-γ Agonist GW1929 Targeted to Macrophages with Dendrimer–Graphene Nanostars Reduces Liver Fibrosis and Inflammation" Pharmaceutics 15, no. 5: 1452.
https://doi.org/10.3390/pharmaceutics15051452
APA Style
Moreno-Lanceta, A., Medrano-Bosch, M., Simón-Codina, B., Barber-González, M., Jiménez, W., & Melgar-Lesmes, P.
(2023). PPAR-γ Agonist GW1929 Targeted to Macrophages with Dendrimer–Graphene Nanostars Reduces Liver Fibrosis and Inflammation. Pharmaceutics, 15(5), 1452.
https://doi.org/10.3390/pharmaceutics15051452
